Literature DB >> 7770069

The down-regulation of IL-6-stimulated fibrinogen steady state mRNA and protein levels by human recombinant IL-1 is not PGE2-dependent: effects of IL-1 receptor antagonist (IL-1RA).

P Conti1, L Bartle, R C Barbacane, M Reale, J D Sipe.   

Abstract

Infections, trauma and inflammatory processes induce a host response with increases in a large group of structurally and functionally diverse plasma proteins. Parental administration of foreign proteins also induce an increase in plasma fibrinogen. Interleukin-6 (IL-6) is a monocyte-derived mediator and has regulatory effects on acute phase protein genes which result in the induction of fibrinogen synthesis in primary hepatocytes, while the addition of interleukin-1 (IL-1) exerts a negative modulating influence on the IL-6-stimulated fibrinogen. In order to understand the mechanisms by which IL-1 inhibits IL-6-stimulated fibrinogen transcription and translation, and since IL-1 is believed to act through PGE2 stimulation, we have studied the influence of PGE2 in IL-6 or IL-1, alone and in combination, on Fg mRNA expression (by Northern blot analysis) and the influence of PGE2, indomethacin, and arachidonic acid on Fg secretion. Moreover, since human recombinant interleukin-1 receptor antagonist (hrIL-1ra) is a strong inhibitor of IL-1 induced IL-1 transcription and translation and has an inhibitory effect on PGE2, we have studied the effects of IL-1ra on the down-regulation of IL-6 stimulated fibrinogen by IL-1, using an Fg ELISA method.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7770069     DOI: 10.1007/BF00928938

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

1.  Prostaglandin E2 in the pathogenesis of pyrogen fever: validation of an intermediary role.

Authors:  F Coceani; I Bishai; J Lees; S Sirko
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1989

2.  Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells.

Authors:  H Baumann; C Richards; J Gauldie
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

Review 3.  The molecular biology of interleukin 1 and the acute phase response.

Authors:  J D Sipe
Journal:  Adv Intern Med       Date:  1989

4.  In vitro enhanced thromboxane B2 release by polymorphonuclear leukocytes and macrophages after treatment with human recombinant interleukin 1.

Authors:  P Conti; M G Cifone; E Alesse; M Reale; C Fieschi; C A Dinarello
Journal:  Prostaglandins       Date:  1986-07

5.  Regulation of tubulin and actin mRNA production in rat brain: expression of a new beta-tubulin mRNA with development.

Authors:  J F Bond; S R Farmer
Journal:  Mol Cell Biol       Date:  1983-08       Impact factor: 4.272

6.  Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever.

Authors:  V Baracos; H P Rodemann; C A Dinarello; A L Goldberg
Journal:  N Engl J Med       Date:  1983-03-10       Impact factor: 91.245

7.  Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes.

Authors:  S H Yap; H J Moshage; B P Hazenberg; H M Roelofs; J Bijzet; P C Limburg; L A Aarden; M H van Rijswijk
Journal:  Biochim Biophys Acta       Date:  1991-02-19

8.  Different regulatory mechanisms for serum amyloid A and serum amyloid P synthesis by cultured mouse hepatocytes.

Authors:  E Tatsuta; J D Sipe; T Shirahama; M Skinner; A S Cohen
Journal:  J Biol Chem       Date:  1983-05-10       Impact factor: 5.157

9.  Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol).

Authors:  R J Flower; J R Vane
Journal:  Nature       Date:  1972-12-15       Impact factor: 49.962

10.  Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction.

Authors:  D J Dripps; B J Brandhuber; R C Thompson; S P Eisenberg
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

View more
  3 in total

1.  Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.

Authors:  X Shen; Z Tian; M J Holtzman; B Gao
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

2.  Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study.

Authors:  Tadashi Okano; Kentaro Inui; Masahiro Tada; Yuko Sugioka; Kenji Mamoto; Shigeyuki Wakitani; Tatsuya Koike; Hiroaki Nakamura
Journal:  Rheumatol Int       Date:  2015-10-05       Impact factor: 2.631

3.  Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increases 3H-thymidine incorporation and the release of [3H]arachidonic acid in human monocytes.

Authors:  M Reale; C Orso; M L Castellani; R C Barbacane; F C Placido; E Porreca; C Di Febbo; I Cataldo; D Vacalis; G Anogianakis; A Trakatellis; P Conti
Journal:  Mol Cell Biochem       Date:  1997-04       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.